Consolidated revenue for the first half of 2025 rose slightly by 1% compared to the first half of 2024, reaching €15,583k. The group achieved a notable performance, with a positive consolidated EBITDA ...

Stroke is no longer an old person’s disease — rates are climbing fastest among adults in their 20s to 40s, reshaping one of ...

B ritish cycling clothing brand Rapha has recorded financial losses for the eighth year in a row, but there is no cause for ...

FalconX and Bridgewater Alum Matthew Sheffield Named Chief Investment Officer Former Bain Capital Crypto Head of Marketing Mandy Campbell Named ...

ThinkEquity will make its rule 10b-18 purchases (as defined in Rule 10b-18 of the Securities Exchange Act of 1934) in ...

Ford and General Motors have navigated choppy waters amid an unpredictable year, but both were just dealt another blow to the ...

Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today a revised full year outlook for 2025 in response to recent ...

BDC stocks trade at a steep 22% NAV discount, reflecting broad investor fear, but this may be a contrarian opportunity. Read why it’s time to be greedy.

UAE corporate tax dictates that the rules of International Financial Reporting Standards must be applied when calculating ...

CLPS Incorporation (the 'Company' or 'CLPS') (Nasdaq: CLPS), today announced its financial results for the six months and full year of fiscal 2025 ended June 30, 2025.

The Drug Testing Systems market is witnessing diverse growth trajectories across global regions. China leads the charge with ...

During the third quarter of 2025, Fifth Third repurchased $300 million of its common stock, which reduced shares outstanding by approximately 6.9 million at quarter end. Fifth Third increased its ...